Implant with composite coating with high osteoinductivity on surface and preparation method of implant
Through microarc oxidation and Sr/CS-TGF-β1 sustained-release microsphere composite coating technology, the problem of slow binding of implants and bone tissue is solved, and the process of bone cell attachment and osteogenesis is accelerated, and the implant is improved. Planting effect and long-term stability.
Patent Information
- Application Number
- CN202411226454.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-29
AI Technical Summary
The existing single coating modification technology on the surface of implants cannot effectively improve the binding speed of titanium implants and bone tissue, resulting in too long healing time, affecting the implant effect and long-term stability.
The titanium surface was treated with microarc oxidation, combined with chitosan gel and Sr solution, and TGF-β1 protein was added dropwise to form a Sr/CS-TGF-β1 sustained-release microsphere composite coating to enhance the osteoinduction of the implant Sexual and biocompatible.
Accelerate the process of osteocyte attachment and osteogenesis, reduce bone binding time, improve the affinity between the implant and bone tissue, enhance the expression of factors and enzymes related to bone tissue formation, and significantly improve the implant effect and long-term stability of the implant.
Smart Images

Figure CN119034001A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an oral implant, in particular to an implant with a composite coating having high bone inductivity on the surface. Background Art
[0002] The formation of a stable structural and functional connection between the implant surface and the patient's bone tissue is important for the implantation effect and long-term stability of the implant. However, bone integration alone has the problem of long healing time, which is not conducive to clinical implantation. Therefore, while ensuring a high implantation success rate, reducing the bone integration time between titanium implants and bone tissue and improving the quality of life of patients have important scientific research and clinical value.
[0003] Strontium (Sr) promotes osteoblast proliferation, differentiation and adhesion, and can also inhibit osteoclast growth, thereby making the implant coating have better osteogenic activity, which is beneficial to bone resorption and bone formation in bone reconstruction. In addition, Sr can enhance the hydrophilicity of chitosan, thereby promoting osteoblast proliferation, migration and attachment to the implant surface, accelerating the bone bonding process. TGF-β1 is beneficial to osteoblast proliferation and differentiation, inhibits osteoclast activity, and improves implant biocompatibility.
[0004] The healing time after implantation depends on the bone-integration speed, which is a very complex process affected by many factors. However, the existing single coating modification technology on the implant surface often cannot meet clinical needs. Therefore, physical, chemical and biological combined modification of the implant surface based on the bone-integration speed is expected to achieve better treatment effects. Summary of the invention
[0005] In view of the above-mentioned shortcomings and deficiencies of the prior art, the present invention proposes a method for preparing an implant having a composite coating with high osteoinductivity on the surface.
[0006] The second object of the present invention is to provide an implant having a composite coating on the surface with high osteoinductivity prepared by the above method.
[0007] To achieve the purpose of the present invention, the following technical solution is provided: A method for preparing an implant having a composite coating with high osteoinductivity on the surface comprises the following steps: (1) The pure titanium is cleaned and degreased, and then polished with sandpaper. The pure titanium is then placed in a silicate electrolyte solution with stainless steel as the cathode and pure titanium as the anode for micro-arc oxidation, and then washed and dried; (2) adding Sr solution dropwise to the chitosan gel, dropping the mixed gel on the pure titanium surface obtained in step (1), and drying after negative pressure treatment; (3) The pure titanium obtained in step (2) is immersed in chitosan gel mixed with gelatin microspheres, EDC is added in an ice bath, NHS is dissolved, and then TGF-β1 protein is immediately added. After drying, an implant with a composite coating on the surface having high osteoinductivity is obtained.
[0008] Preferably, the silicate electrolyte solution in step (1) contains 8.5 g / L of Na 2 SiO 3 , 2.5g / L NaOH, 2.5g / L sodium citrate, 3g / L Na 2 WO 4 .
[0009] Preferably, the micro-arc oxidation in step (1) adopts an operating voltage of 700 V, a time of 1 h, and a temperature below 35° C.
[0010] Preferably, the Sr concentration in the chitosan gel in step (2) is 0.05 g / ml, and the chitosan mass fraction is 0.5 g / ml.
[0011] Preferably, the negative pressure treatment time in step (2) is 15 minutes and the drying time is 24 hours.
[0012] Preferably, the concentration of gelatin microspheres in the chitosan gel in step (3) is 0.04 g / ml, and the concentration of chitosan is 0.2 g / ml.
[0013] Preferably, the amount of EDC added in step (3) is 0.1 g.
[0014] Preferably, the amount of NHS added in step (3) is 0.15 g.
[0015] Preferably, the TGF-β1 protein concentration in step (3) is 30 ng / ml.
[0016] Compared with the prior art, the present invention has the following advantages and beneficial effects: The present invention performs micro-arc oxidation pretreatment on the implant, which can increase the rough porous structure of the titanium surface and is beneficial to promoting the attachment of bone cells.
[0017] After the implant is implanted, the bone-integrating substances in the coating can be released around the implant, which accelerates the bone-integration process in the bone defect area.
[0018] The present invention constructs a Sr / CS-TGF-β1 sustained-release microsphere composite coating. The composite of the three materials can accelerate the spreading speed of bone cells on the surface of the coating material and enhance the expression of factors and enzymes (Runx2 and alkaline phosphatase) related to bone tissue formation. In addition, the addition of Sr increases the roughness of the coating surface and the hydrophilicity of chitosan, effectively enhancing the affinity between the implant and bone tissue, and has good clinical prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] The technical solution of the present invention is further described in detail below in conjunction with the accompanying drawings, but does not constitute any limitation to the present invention.
[0020] Figure 1 This is a graph showing the in vitro drug release results of implants with Sr / CS-TGF-β1 sustained-release microsphere composite coating loaded on the surface. DETAILED DESCRIPTION
[0021] The content of the present invention will be further described below in conjunction with the accompanying drawings and specific examples, but it should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, the modifications or replacements made to the method, steps, and conditions of the present invention all belong to the scope of the present invention. Unless otherwise specified, the experimental methods used in the examples are conventional methods and techniques well known to those skilled in the art, and reagents or materials are obtained through commercial channels unless otherwise specified. Any non-substantial changes and replacements made by those skilled in the art on the basis of the present invention all belong to the scope of protection claimed in the present invention.
[0022] Example 1: Preparation of implants with Sr / CS-TGF-β1 sustained-release microsphere composite coatings on the surface (1) Commercial medical TA2 pure titanium was used to process a Φ 3.3 mm*6 mm dental cylindrical implant matrix, which was cleaned and degreased, and polished with sandpaper. The matrix was then placed in a solution containing 8.5 g / L Na 2 SiO 3 , 2.5g / L NaOH, 2.5g / L sodium citrate, 3g / L Na 2 WO 4 In a silicate electrolyte solution, stainless steel is used as cathode and the substrate is used as anode for constant voltage micro-arc oxidation at a high voltage of 700V for 1h at a temperature below 35°C, and then washed and dried; (2) Sr solution was added dropwise to the chitosan gel to prepare a mixed gel with an Sr concentration of 0.05 g / ml and a chitosan mass fraction of 0.5 g / ml, and the mixed gel was added dropwise to the pure titanium surface obtained in step (1), and the mixture was treated with negative pressure for 15 min and then dried for 24 h; (3) The pure titanium obtained in step (2) was immersed in 0.2 g / ml chitosan gel mixed with 0.04 g / ml gelatin microspheres, and 0.1 g EDC and 0.15 g dissolved NHS were added under ice bath, followed by immediate addition of 30 ng / ml TGF-β1 protein. After drying, an implant with a surface loaded with Sr / CS-TGF-β1 sustained-release microsphere composite coating was obtained.
[0023] Example 2: Preparation of implants with Sr / CS-TGF-β1 sustained-release microsphere composite coatings on the surface (1) Commercial medical TA2 pure titanium was used to process a Φ 3.3 mm*6 mm dental cylindrical implant matrix, which was cleaned and degreased, and polished with sandpaper. The matrix was then placed in a solution containing 8.5 g / L Na 2 SiO 3 , 2.5g / L NaOH, 2.5g / L sodium citrate, 3g / L Na 2 WO 4 In a silicate electrolyte solution, stainless steel is used as cathode and the substrate is used as anode for constant voltage micro-arc oxidation at a high voltage of 700V for 1h at a temperature below 35°C, and then washed and dried; (2) Sr solution was added dropwise to the chitosan gel to prepare a mixed gel with an Sr concentration of 0.025 g / ml and a chitosan mass fraction of 0.5 g / ml, and the mixed gel was added dropwise to the pure titanium surface obtained in step (1), and the mixture was treated with negative pressure for 15 min and then dried for 24 h; (3) The pure titanium obtained in step (2) was immersed in 0.2 g / ml chitosan gel mixed with 0.04 g / ml gelatin microspheres, and 0.1 g EDC and 0.15 g dissolved NHS were added under ice bath, followed by immediate addition of 30 ng / ml TGF-β1 protein. After drying, an implant with a surface loaded with Sr / CS-TGF-β1 sustained-release microsphere composite coating was obtained.
[0024] Example 3: Preparation of implants with Sr / CS-TGF-β1 sustained-release microsphere composite coatings on the surface (1) Commercial medical TA2 pure titanium was used to process a Φ 3.3 mm*6 mm dental cylindrical implant matrix, which was cleaned and degreased, and polished with sandpaper. The matrix was then placed in a solution containing 8.5 g / L Na 2 SiO 3 , 2.5g / L NaOH, 2.5g / L sodium citrate, 3g / L Na 2 WO 4 In a silicate electrolyte solution, stainless steel is used as cathode and the substrate is used as anode for constant voltage micro-arc oxidation at a high voltage of 700V for 1h at a temperature below 35°C, and then washed and dried; (2) Sr solution was added dropwise to the chitosan gel to prepare a mixed gel with an Sr concentration of 0.075 g / ml and a chitosan mass fraction of 0.5 g / ml, and the mixed gel was added dropwise to the pure titanium surface obtained in step (1), and the mixture was treated with negative pressure for 15 min and then dried for 24 h; (3) The pure titanium obtained in step (2) was immersed in 0.2 g / ml chitosan gel mixed with 0.04 g / ml gelatin microspheres, and 0.1 g EDC and 0.15 g dissolved NHS were added under ice bath, followed by immediate addition of 30 ng / ml TGF-β1 protein. After drying, an implant with a surface loaded with Sr / CS-TGF-β1 sustained-release microsphere composite coating was obtained.
[0025] Example 4: Detection of in vitro drug release from implants with Sr / CS-TGF-β1 sustained-release microsphere composite coatings loaded on their surfaces.
[0026] The quantitative analysis of the in vitro drug release of implants loaded with Sr / CS-TGF-β1 slow-release microsphere composite coatings showed that the release of TGF-β1 reached (27.6±1.5)% and (32.4±1.3)% at 6h and 1d, respectively. The release reached (57.8±2.0)% at 7d, and the protein release concentration reached (81.1±1.2)% at 14d.
[0027] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A method for preparing an implant having a composite coating with high osteoinductivity on the surface, characterized in that: Here are the steps: (1) The pure titanium is cleaned and degreased, and then polished with sandpaper. The pure titanium is then placed in a silicate electrolyte solution with stainless steel as the cathode and pure titanium as the anode for micro-arc oxidation, and then washed and dried; (2) adding Sr solution dropwise to the chitosan gel, dropping the mixed gel on the pure titanium surface obtained in step (1), and drying after negative pressure treatment; (3) The pure titanium obtained in step (2) is immersed in chitosan gel mixed with gelatin microspheres, EDC is added in an ice bath, NHS is dissolved, and then TGF-β1 protein is immediately added. After drying, an implant with a composite coating on the surface having high osteoinductivity is obtained.
2. The method for preparing an implant having a composite coating with high osteoinductivity on the surface according to claim 1, characterized in that: The silicate electrolyte solution in step (1) contains 8.5 g / L of Na2SiO3, 2.5 g / L of NaOH, 2.5 g / L of sodium citrate, and 3 g / L of Na2WO4.
3. The method for preparing an implant having a composite coating with high osteoinductivity on the surface according to claim 1, characterized in that: The micro-arc oxidation in step (1) adopts an operating voltage of 700 V, a micro-arc oxidation time of 1 hour, and a micro-arc oxidation temperature of below 35°C.
4. The method for preparing an implant having a composite coating with high osteoinductivity on the surface according to claim 1, characterized in that: The Sr concentration in the chitosan gel in step (2) is 0.05 g / ml, and the chitosan mass fraction is 0.5 g / ml.
5. The method for preparing an implant having a composite coating with high osteoinductivity on the surface according to claim 1, characterized in that: In the chitosan gel in step (3), the concentration of gelatin microspheres is 0.04 g / ml, the concentration of chitosan is 0.2 g / ml, the amount of EDC added is 0.1 g, the amount of NHS added is 0.15 g, and the concentration of TGF-β1 protein is 30 ng / ml.
6. An implant having a composite coating with high osteoinductivity on the surface, prepared according to the method of any one of claims 1 to 5.
Citation Information
Cited By
Dental implant with high-biological-activity surface coating and preparation method of dental implant
CN121490134A
